1. Off-Label Prescribing of Erythropoiesis-Stimulating Proteins in US Hospitals

   • Anuprita Patkar
   • David Holdford
   • Michael Pyles

   Labeling and Advertising 30 December 2007 Pages: 431 - 440

2. Evaluation of Electronic Information Resources for Questions Received by a College of Pharmacy Drug Information Center

   • Lamya S. Alnaim
   • Nermeen N. Abuelsoud

   Drug Information 30 December 2007 Pages: 441 - 448

3. Tracking the Growth of Drug Therapy Literature Using PubMed

   • Dennis F. Thompson
   • Nancy Toedter Williams

   Drug Information 30 December 2007 Pages: 449 - 455

4. Survey of Medical Liaison Practices across the Pharmaceutical Industry

   • Christopher M. Marrone
   • J. Lynn Bass
   • Craig J. Klinger

   Drug Information 30 December 2007 Pages: 457 - 470

5. An Investigation of Drug Information Needs of Nigerian Pharmacists

   • Waka A. Udezi
   • Azuka C. Oparah
   • Kenneth U. Enyi

   Drug Information 30 December 2007 Pages: 471 - 479

6. Design and Analysis for Drug Abuse Potential Studies: Issues and Strategies for Implementing a Crossover Design

   • Ling Chen
   • Yi Tsong

   Drug Information 30 December 2007 Pages: 481 - 489

7. Is There a Price to Pay for Short-Term Savings in the Clinical Development of New Pharmaceutical Products?

   • Shelby D. Reed
   • Robert M. Califf
   • Kevin A. Schulman

   Pharmacoeconomics 30 December 2007 Pages: 491 - 499

8. The Economics of Personalized Medicine: A Model of Incentives for Value Creation and Capture

   • Louis P. Garrison Jr.
   • M. J. Finley Austin

   Pharmacoeconomics 30 December 2007 Pages: 501 - 509

9. Statistical Considerations for Some Studies of Over-the-Counter Drugs

   • Stan C. Lin

   Biostatistics & Analysis 30 December 2007 Pages: 511 - 516

10. On the Efficiency of Interim Analyses Applied to Nonclinical Studies

    • SFdS, Groupe Biopharmacie et Santé, Good Preclinical Statistical Practices Working Party
    • L. Maïofiss-Dullin
    • V. Onado

    Biostatistics & Analysis 30 December 2007 Pages: 517 - 526

11. A Transition Model for Analysis of Repeated Measure Ordinal Response Data to Identify the Effects of Different Treatments

    • M. Ganjali
    • Z. Rezaee

    Biostatistics & Analysis 30 December 2007 Pages: 527 - 534

12. Consequences of Delayed Treatment Effects on Analysis of Time-to-Event Endpoints

    • Gil D. Fine

    Biostatistics & Analysis 30 December 2007 Pages: 535 - 539

13. Enhanced Interpretation of Instrument Scales Using the Rasch Model

    • John R. Thompson
    • Joseph C. Cappelleri
    • Sebastian Wolf

    Biostatistics & Analysis 30 December 2007 Pages: 541 - 550